Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.
暂无分享,去创建一个
Anneliese O. Speak | A. Speak | W. Ouwehand | A. Rendon | P. Nurden | W. Erber | L. van der Weyden | J. Estabel | C. Ghevaert | J. Guerrero | J. A. Guerrero | C. Bennett | L. van der Weyden | H. McKinney | M. Chin | P. Nurden | Z. McIntyre | E. L. Cambridge | J. Estabel | H. Wardle-Jones | A. O. Speak | W. N. Erber | A. Rendon | W. H. Ouwehand | C. Ghevaert | H. Wardle-Jones | H. McKinney | E. Cambridge | M. Chin | Zoe McIntyre | Cavan Bennett | Melody Chin
[1] H. Hasselbalch. The role of cytokines in the initiation and progression of myelofibrosis. , 2013, Cytokine & growth factor reviews.
[2] N. Debili,et al. Multivesicular Bodies Are an Intermediate Stage in the Formation of Platelet α-Granules , 1998 .
[3] Laurie J. Gay,et al. Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.
[4] White Jg. Ultrastructural studies of the gray platelet syndrome. , 1979 .
[5] G. Raccuglia. Gray platelet syndrome. A variety of qualitative platelet disorder. , 1971, The American journal of medicine.
[6] A. Green,et al. JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. , 2013, Blood.
[7] Jurgen Del-Favero,et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. , 2010, Human molecular genetics.
[8] Ajit Varki,et al. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] N. Callewaert,et al. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. , 2007, Glycobiology.
[10] Gianni Tognoni,et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials , 2012, The Lancet.
[11] References , 1971 .
[12] J. Harrow,et al. A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.
[13] D. Maynard,et al. The α‐granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome , 2010, Journal of thrombosis and haemostasis : JTH.
[14] V. Seshan,et al. A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.
[15] P. Bork,et al. Identification and mutation analysis of the complete gene for Chediak–Higashi syndrome , 1996, Nature Genetics.
[16] C P Charles. National Health Service. , 1971, The Medical journal of Australia.
[17] G. Cagney,et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.
[18] P. Nurden,et al. The gray platelet syndrome: clinical spectrum of the disease. , 2007, Blood reviews.
[19] W. Vainchenker,et al. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. , 1985, Blood.
[20] S. Russell,et al. Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation. , 2009, Blood.
[21] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Nurden,et al. Platelets and wound healing. , 2008, Frontiers in bioscience : a journal and virtual library.
[23] A. Varki,et al. P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Ambrosio,et al. Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system. , 2012, Blood.
[25] Richard W. Farndale,et al. Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.
[26] F. Wendling,et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. , 2000, Blood.
[27] J. Mullikin,et al. NBEAL2 is mutated in Gray Platelet Syndrome and is required for biogenesis of platelet alpha-granules , 2011, Nature Genetics.
[28] R. Jain,et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Flaumenhaft,et al. Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.
[30] E. Battinelli,et al. Selective sorting of alpha‐granule proteins , 2009, Journal of thrombosis and haemostasis : JTH.
[31] B. Storrie,et al. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release , 2007, Journal of thrombosis and haemostasis : JTH.
[32] R. Ramirez-Solis,et al. Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource , 2013, Mammalian Genome.
[33] A. Tefferi,et al. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Ware,et al. Platelets: Linking Hemostasis and Cancer , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[35] W. Vainchenker,et al. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. , 1981, The American journal of pathology.
[36] Damian Smedley,et al. Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes , 2013, Cell.
[37] David R. Nadeau,et al. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] L. Suva,et al. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells , 2011, Breast Cancer Research.
[39] U. Schumacher,et al. E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung , 2009, British Journal of Cancer.
[40] T. Kieber‐Emmons,et al. Chondroitin sulfate glycosaminoglycans as major P‐selectin ligands on metastatic breast cancer cell lines , 2007, International journal of cancer.
[41] S. Jackson. Arterial thrombosis—insidious, unpredictable and deadly , 2011, Nature Medicine.
[42] T. Barbui,et al. JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations , 2011, Leukemia.
[43] C. Hawkins,et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. , 2013, Blood.
[44] Gregory E. Jordan,et al. Exome sequencing identifies NBEAL2 as the causative gene for Gray Platelet Syndrome , 2011, Nature Genetics.
[45] Joseph E Italiano,et al. The biogenesis of platelets from megakaryocyte proplatelets. , 2005, The Journal of clinical investigation.
[46] J. White,et al. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. , 2001, Molecular genetics and metabolism.
[47] J. Parkinson,et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome , 2011, Nature Genetics.
[48] N. Debili,et al. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. , 1998, Blood.
[49] W. Mitchell,et al. Ex Vivo production of platelets from stem cells , 2014, British journal of haematology.
[50] J. Freedman,et al. Platelets and the immune continuum , 2011, Nature Reviews Immunology.